Aardvark Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	231	-	-	-
Enterprise Value	85	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02
Quick Ratio	13.76	14.95	7.23	27.07
Current Ratio	14.04	15.05	7.50	27.72
Return on Equity (ROE)	-33.09%	-50.70%	-57.47%	-
Return on Assets (ROA)	-21.76%	-32.35%	-33.96%	-
Return on Capital (ROIC)	-22.98%	-34.67%	-36.34%	-
Buyback Yield / Dilution	-170.94%	-0.90%	-1.78%	-

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q